Antibiotics modulate activity of mouse and human dorsal root ganglia neurons
This study demonstrates that clinically relevant concentrations of various antibiotics directly modulate mouse and human dorsal root ganglion neuron activity by inducing calcium flux through divergent mechanisms, such as TRPA1 activation or mitochondrial ROS production, thereby revealing a previously unexplored source of antibiotic side effects.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Every day, billions of people take antibiotics to fight bacterial infections. These medicines are among the most prescribed in the world, transforming modern healthcare by saving lives from dangerous bacteria. However, while scientists have long understood how these drugs kill microbes, their direct effects on the human body's own cells have remained largely a mystery. We know that antibiotics can cause side effects like stomach pain or tendon damage, but the biological reasons behind these reactions have been unclear. A key question has been whether these drugs interact directly with our nerve cells, which are responsible for sensing pain and movement, or if their effects are purely a result of killing bacteria and disrupting the gut's ecosystem.
A new study from researchers at the University of Texas at Dallas and the University of Kentucky investigates this possibility by looking at the dorsal root ganglia. These are clusters of nerve cells located just outside the spinal cord that act as the body's primary sensors for pain and touch. Because these nerves reach into the gut and are directly exposed to drugs circulating in the blood, they are a logical place to look for unexpected interactions. The researchers wanted to know if common antibiotics, at the concentrations found in a patient's blood, could directly wake up these nerve cells and make them fire signals, even in the absence of an infection.
To find the answer, the team grew nerve cells from mice and humans in a laboratory dish. They loaded these cells with a special dye that glows brighter when calcium, a chemical messenger, flows into the cell. This allowed them to watch the nerves in real time as they applied four of the most frequently prescribed oral antibiotics: amoxicillin, cephalexin, azithromycin, and doxycycline. The results were immediate and surprising. Within minutes of exposure, significant numbers of these nerve cells began to glow, indicating that the drugs had triggered a surge of activity. This happened even though the cells were not infected with bacteria, proving that the antibiotics were acting directly on the nerves themselves.
The study revealed that not all antibiotics work the same way, and the response varied depending on the specific drug and the type of nerve cell. For instance, doxycycline was the most potent, causing nearly half of the small, pain-sensing nerve cells from mice to fire. Other drugs, like amoxicillin and cephalexin, activated a smaller but still significant portion of these cells. The researchers also tested human nerve cells and found similar patterns, confirming that this is not just a quirk of mouse biology but a phenomenon that likely occurs in people as well. Interestingly, the size of the nerve cell mattered; the drugs tended to target the smaller cells, which are the ones responsible for detecting pain, rather than the larger cells that control muscle movement.
To understand how these drugs were causing the nerves to fire, the scientists performed a series of careful experiments to block different parts of the cell's machinery. They discovered that all the antibiotics required calcium from the outside of the cell to trigger this response. Without calcium in the surrounding fluid, the drugs had no effect. However, the specific path the drugs took to get there differed. For cephalexin, the researchers found that the drug likely latches onto a specific protein channel on the nerve cell surface called TRPA1, which acts as a gate for calcium. When they blocked this channel, the drug stopped working. In contrast, doxycycline took a different route. It appeared to enter the cell and disturb the mitochondria, the tiny power plants inside the cell that generate energy. This disturbance caused the mitochondria to produce reactive oxygen species, a form of cellular stress that eventually signaled the nerve to fire.
The team then moved from the lab dish to living mice to see if these cellular reactions translated into actual feelings of pain. They gave mice oral doses of these antibiotics and watched their behavior closely. The mice showed clear signs of discomfort, such as squinting their eyes and tightening their facial muscles, which are known indicators of pain in rodents. They also became more sensitive to touch on their bellies. While the effects were not as severe as a major injury, the changes were consistent and measurable, suggesting that the drugs were indeed causing a low level of ongoing pain or irritation. One drug, azithromycin, also caused a change in the water content of the mice's stool, hinting at a link between nerve activation and gut movement.
These findings suggest that the side effects people sometimes feel after taking antibiotics, such as unexplained aches or stomach cramps, might be caused by the drugs directly irritating the nervous system. This is particularly important because these drugs are often prescribed to people who are already in pain from an infection, potentially masking the drug's own contribution to their discomfort. Furthermore, the study highlights that the mechanisms are complex and drug-specific; what works for one antibiotic does not necessarily apply to another. While the research was conducted in a controlled setting and does not yet prove that these effects cause chronic pain in humans, it provides a clear biological explanation for why these widely used medicines might make some people feel worse in ways that have nothing to do with their infection. The work opens a new door for understanding how common medicines interact with our bodies, reminding us that even life-saving drugs have a direct conversation with our nerves.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.